What is DiGeorge syndrome?
DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is a rare genetic disorder caused by a small missing piece of chromosome 22. This immunodeficiency condition affects multiple body systems, causing problems with immune function, heart development, calcium regulation, and facial features. The syndrome occurs in approximately 1 in 4,000 births, making it one of the most common microdeletion syndromes. While symptoms vary widely between individuals, early diagnosis and comprehensive care can significantly improve outcomes and quality of life.
Key statistics
| Prevalence | 1 in 4,000 births |
| Inheritance pattern | Autosomal dominant (90% de novo mutations) |
| Age of diagnosis | Infancy to childhood (often within first year) |
| Life expectancy | Near normal with proper management |
Symptoms
Common features: Conotruncal heart defects, hypocalcemia, T-cell immunodeficiency, cleft palate, characteristic facial features, developmental delays, learning difficulties, psychiatric conditions.
The clinical presentation of DiGeorge syndrome varies dramatically, with some individuals having severe, life-threatening complications while others experience mild symptoms. Heart defects, particularly conotruncal abnormalities like tetralogy of Fallot, interrupted aortic arch, and ventricular septal defects, occur in approximately 75% of patients and often require surgical intervention in infancy.
Immunodeficiency results from absent or underdeveloped thymus glands, leading to reduced T-cell production and increased susceptibility to infections. Hypocalcemia develops due to hypoparathyroidism from absent or underdeveloped parathyroid glands, causing seizures, muscle cramps, and tetany in newborns and infants.
Characteristic facial features include a long face, almond-shaped eyes, wide nasal bridge, small ears, and cleft palate or submucous cleft. Developmental delays are common, ranging from mild learning disabilities to significant intellectual impairment. Speech and language delays frequently occur, often related to palatal abnormalities and hearing problems.
Psychiatric conditions become more apparent with age, including attention deficit hyperactivity disorder, anxiety disorders, autism spectrum disorders, and an increased risk of schizophrenia in adolescence and adulthood. Feeding difficulties, failure to thrive, and gastrointestinal problems may also be present in infancy.
Causes and risk factors
DiGeorge syndrome is caused by a microdeletion on the long arm of chromosome 22 (22q11.2), resulting in the loss of approximately 30-40 genes. This deletion disrupts normal embryonic development of the third and fourth pharyngeal pouches, which give rise to the thymus, parathyroid glands, and certain facial structures.
Approximately 90% of cases result from de novo (new) mutations, meaning neither parent carries the deletion. The remaining 10% are inherited from an affected parent in an autosomal dominant pattern, where only one copy of the deleted chromosome is needed to cause the condition. Advanced maternal age slightly increases the risk of de novo deletions.
The deletion size varies among individuals, with larger deletions generally associated with more severe symptoms. Environmental factors do not appear to influence the development of DiGeorge syndrome, as it is purely genetic in origin.
Prevention
As DiGeorge syndrome is a genetic condition caused by chromosomal deletions, it cannot be prevented through lifestyle modifications or environmental changes. However, genetic counseling and testing options are available for families.
Preconception genetic counseling is recommended for individuals with DiGeorge syndrome who are planning pregnancy, as they have a 50% chance of passing the condition to each child. Prenatal testing through chorionic villus sampling or amniocentesis can detect the 22q11.2 deletion during pregnancy. Preimplantation genetic testing may be an option for couples using assisted reproductive technology.
For families with no known history of the condition, routine prenatal screening may identify some cases through fetal heart abnormalities detected on ultrasound, though this is not a reliable screening method for all affected pregnancies.
Complications
Without proper management, DiGeorge syndrome can lead to serious, life-threatening complications. Severe heart defects may cause heart failure, cyanosis, and growth failure in infancy, potentially requiring emergency cardiac surgery. Profound immunodeficiency increases the risk of severe, recurrent infections that can be fatal without appropriate medical intervention.
Untreated hypocalcemia can cause seizures, laryngospasm, and cardiac arrhythmias. Chronic complications include increased susceptibility to autoimmune disorders, chronic kidney disease, scoliosis, and hearing loss. The risk of developing psychiatric disorders, particularly schizophrenia, is significantly elevated compared to the general population.
Educational and developmental challenges may lead to social isolation and reduced quality of life without appropriate support services. Adults may face difficulties with independent living, employment, and forming relationships.
Diagnosis
Diagnosis of DiGeorge syndrome requires a combination of clinical evaluation and genetic testing. The clinical diagnosis is often suspected based on the presence of characteristic features, particularly the combination of conotruncal heart defects, hypocalcemia, immunodeficiency, and facial dysmorphism.
Fluorescence in situ hybridization (FISH) testing or chromosomal microarray analysis can detect the 22q11.2 deletion with high accuracy. Multiplex ligation-dependent probe amplification (MLPA) is another sensitive method for detecting this deletion.
Laboratory studies typically include complete blood count with lymphocyte subsets to assess T-cell numbers and function, serum calcium and parathyroid hormone levels, and immunoglobulin levels. Echocardiography or cardiac catheterization may be necessary to evaluate heart defects. Additional testing may include renal ultrasound, hearing assessment, and developmental evaluations.
Newborn screening programs in some regions now include T-cell receptor excision circle (TREC) testing, which can identify severe T-cell immunodeficiency and lead to earlier diagnosis of DiGeorge syndrome.
Treatment
Treatment for DiGeorge syndrome requires a multidisciplinary approach addressing each affected system. Cardiac surgery is often necessary in infancy to repair heart defects, with procedures ranging from simple defect closure to complex reconstructions.
Immunodeficiency management may include prophylactic antibiotics, immunoglobulin replacement therapy, and careful monitoring for infections. In severe cases, thymus transplantation or bone marrow transplantation may be considered. Live vaccines are contraindicated in patients with severe T-cell deficiency.
Hypocalcemia is treated with calcium supplementation and active vitamin D analogues such as calcitriol. Some patients may also require magnesium supplementation. Regular monitoring of calcium levels is essential to prevent complications.
Cleft palate repair and other reconstructive surgeries may be necessary to address feeding difficulties and speech problems. Speech therapy, occupational therapy, and physical therapy play important roles in developmental support.
Psychiatric conditions require appropriate medications and behavioral interventions. Early intervention programs and special education services help address developmental delays and learning difficulties.
Prognosis
The prognosis for individuals with DiGeorge syndrome has improved significantly with advances in medical care and early intervention. Life expectancy is near normal for most patients when complications are properly managed. The severity of heart defects and degree of immunodeficiency are the primary factors influencing long-term outcomes.
Children with mild to moderate symptoms often lead relatively normal lives with appropriate support. Those with severe heart defects or profound immunodeficiency face more challenges but can still achieve good outcomes with comprehensive medical care. Educational achievement varies widely, with many individuals completing high school and some pursuing higher education or vocational training.
Early diagnosis and intervention are crucial for optimizing outcomes. Regular follow-up with specialists helps prevent complications and ensures appropriate treatment adjustments as children grow and develop.
Quality of life
Individuals with DiGeorge syndrome can enjoy fulfilling lives with proper support and management. Daily routines may require some modifications, including regular medications, dietary supplements, and infection prevention measures. Maintaining good hygiene and avoiding sick contacts helps reduce infection risk.
A balanced diet rich in calcium and vitamin D supports bone health, while regular exercise within individual limitations promotes overall fitness. Sleep quality may be affected by medical complications, requiring attention to sleep hygiene and treatment of underlying issues.
Mental health support is crucial, as anxiety and depression are common. Building social skills and maintaining friendships may require additional support but greatly enhance quality of life. Educational accommodations help students succeed academically while building self-confidence.
Many adults with DiGeorge syndrome maintain employment, live independently or with minimal support, and form meaningful relationships. Support groups and advocacy organizations provide valuable resources for navigating challenges and celebrating achievements.
Pregnancy and fertility
Fertility is generally preserved in individuals with DiGeorge syndrome, though some may experience challenges related to associated health conditions. Women with the condition require specialized prenatal care due to increased risks of pregnancy complications and a 50% chance of passing the deletion to their children.
Cardiac status must be carefully evaluated before pregnancy, as some heart conditions may pose risks during pregnancy and delivery. Calcium metabolism requires close monitoring, and medication adjustments may be necessary. Genetic counseling is essential to discuss inheritance risks and testing options.
Men with DiGeorge syndrome may father children but should also receive genetic counseling regarding transmission risks. Preconception health optimization and genetic testing discussions benefit all individuals with the condition considering parenthood.
Children
Children with DiGeorge syndrome benefit from early intervention and comprehensive care coordination. Regular monitoring includes cardiac assessments, immune function tests, calcium levels, growth parameters, and developmental milestones. Educational planning should begin early, with many children qualifying for special education services.
Social skills development and peer interaction opportunities are important for building confidence and relationships. Family support and education help parents advocate effectively for their child’s needs while maintaining normal family dynamics as much as possible.
Transition planning to adult care should begin in adolescence, ensuring continuity of medical management and development of self-advocacy skills.
When to see a doctor
Immediate medical attention is required for signs of cardiac distress (difficulty breathing, blue coloration, poor feeding), seizures, or severe infections. Parents should contact healthcare providers promptly for unusual fatigue, recurrent infections, muscle cramps, or developmental concerns.
Routine follow-up appointments with specialists should be maintained throughout life, including cardiology, immunology, endocrinology, and other specialists as needed. Regular monitoring allows for early detection and treatment of complications.
Emergency care may be necessary for cardiac emergencies, severe hypocalcemia, or serious infections that don’t respond to routine treatment.
Regional context
Limited data exists regarding the prevalence of DiGeorge syndrome specifically in the Caucasus region (Georgia, Armenia, Azerbaijan) and broader Eastern Mediterranean area. The condition likely occurs at similar rates to global populations, but regional studies would provide valuable insights into local genetic variations and healthcare access challenges.
The Georgian Medical Journal welcomes research contributions and case reports from healthcare providers in the Caucasus and Eastern Mediterranean regions to better understand the regional epidemiology and clinical presentation of DiGeorge syndrome in these populations.
Research and clinical trials
Current research focuses on improving thymus transplantation techniques, developing new immunotherapy approaches, and understanding the psychiatric manifestations of DiGeorge syndrome. Gene therapy approaches are being investigated, though they remain experimental.
Studies of cognitive development and educational interventions are helping optimize support strategies. Research into the genetic mechanisms underlying variable expressivity may lead to personalized treatment approaches.
Clinical trials for DiGeorge syndrome can be found at ClinicalTrials.gov, including studies of thymus transplantation, immunomodulatory therapies, and behavioral interventions. Patients and families are encouraged to discuss clinical trial participation with their healthcare providers.
Frequently asked questions
Is DiGeorge syndrome inherited?
While DiGeorge syndrome can be inherited, about 90% of cases result from new genetic changes that occur spontaneously. When inherited, it follows an autosomal dominant pattern with a 50% chance of transmission to each child.
Can children with DiGeorge syndrome attend regular school?
Many children with DiGeorge syndrome can attend regular school with appropriate accommodations and support services. The level of support needed varies depending on individual learning needs and health considerations.
What vaccines are safe for people with DiGeorge syndrome?
Most routine vaccines are safe, but live vaccines (such as MMR, varicella, and rotavirus) may be contraindicated in individuals with severe T-cell deficiency. Vaccination decisions should always be made in consultation with immunology specialists.
Will my child with DiGeorge syndrome be able to live independently as an adult?
Many adults with DiGeorge syndrome live independently or with minimal support. The level of independence achieved depends on various factors including cognitive abilities, health status, and available support systems.
How often should someone with DiGeorge syndrome see doctors?
The frequency of medical visits depends on individual health needs and age. Children typically require more frequent monitoring, while stable adults may see specialists annually or as needed. A care coordinator can help manage the complex medical needs.
Support and resources
International 22q11.2 Foundation
Website: www.22q.org
Provides education, support, and advocacy for individuals and families affected by DiGeorge syndrome.
National Organization for Rare Disorders (NORD)
Website: rarediseases.org
Offers information and support for rare disease patients and families.
Orphanet
Website: www.orpha.net
European reference portal for rare diseases and orphan drugs.
EURORDIS (European Organisation for Rare Diseases)
Website: www.eurordis.org
Advocates for rare disease patients across Europe.
Related conditions
Severe Combined Immunodeficiency (SCID)
CHARGE Syndrome
Velocardiofacial Syndrome
Common Variable Immunodeficiency
Hypoparathyroidism
Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, relevant guidelines. Informational only; not medical advice. CC BY 4.0.
Cite this page
GMJ News Desk. “DiGeorge syndrome.” GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/condition/digeorge-syndrome/
Licensed under CC BY 4.0. Free to share with attribution to GMJ News.Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.
Was this article helpful?